USA Financial Formulas’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$603 Hold
5
﹤0.01% 375
2026
Q1
$415 Sell
5
-1
-17% -$86 ﹤0.01% 407
2025
Q4
$513 Buy
+6
New +$502 ﹤0.01% 366
2023
Q3
Sell
-51
Closed -$5.73K 506
2023
Q2
$5.73K Buy
+51
New +$6.08K 0.01% 212
2022
Q1
Sell
-1,252
Closed -$161K 376
2021
Q4
$161K Sell
1,252
-558
-31% -$86K 0.14% 90
2021
Q3
$260K Sell
1,810
-966
-35% -$133K 0.23% 107
2021
Q2
$323K Sell
2,776
-867
-24% -$85.3K 0.27% 106
2021
Q1
$293K Buy
3,643
+1,020
+39% +$77.8K 0.24% 105
2020
Q4
$164K Buy
+2,623
New +$150K 0.13% 133
2019
Q3
Sell
-11,660
Closed -$300K 217
2019
Q2
$300K Buy
11,660
+1,778
+18% +$41.2K 0.15% 82
2019
Q1
$254K Sell
9,882
-527
-5% -$14.4K 0.16% 79
2018
Q4
$222K Buy
+10,409
New +$243K 0.06% 250
2018
Q3
Sell
-27,279
Closed -$443K 292
2018
Q2
$443K Hold
27,279
0.11% 149
2018
Q1
$443K Buy
+27,279
New +$378K 0.11% 149

Other funds holding CROX

USA Financial Formulas's CROX Position: Q2 2026 in Review

USA Financial Formulas held its Crocs (CROX) position steady in Q2 2026 at 5 shares worth $603. The position accounts for ﹤0.01% of the portfolio, ranked #375.

USA Financial Formulas first reported a position in CROX in Q1 2018 and has held it in 14 quarters since. The position peaked at $443K in Q2 2018. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • USA Financial Formulas held 5 shares of Crocs worth $603 as of Q2 2026.
  • USA Financial Formulas left its Crocs share count unchanged in Q2 2026.
  • Crocs made up ﹤0.01% of USA Financial Formulas's portfolio in Q2 2026, its #375 holding.
  • USA Financial Formulas first reported a position in Crocs in Q1 2018 and has held it in 14 quarters since.
  • USA Financial Formulas's Crocs position peaked at $443K in Q2 2018.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.